Novo Nordisk A/S

NOV XETRA / Francfort Healthcare & Biotech Monde
33.70 €
0.24 %

Novo Nordisk A/S is a global pharmaceutical company focused on the research, development, and marketing of treatments for diabetes and other serious hormonal diseases.

diabetes pharmaceutical